tiprankstipranks

Matthew T. Wiley Insider Profile

4 Followers
Matthew T. Wiley, CCO at Foamix Pharma, holds 3.50K shares in Bioxcel Therapeutics (Ticker: BTAI), holds 109.25K shares in VYNE Therapeutics (Ticker: VYNE), holds 112.08K shares in Foamix Pharma (Ticker: FOMX).
tipranks
Matthew T. Wiley

Matthew T. Wiley
Foamix Pharma (FOMX)
CCO

Not Ranked
Matthew T. Wiley has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$220K
97.96%
2.04%
A breakdown of Matthew T. Wiley's holdings

Insider Roles

VYNE Therapeutics
(VYNE)
CCO
Bioxcel Therapeutics
(BTAI)
CCO
Roles that Matthew T. Wiley holds in companies

Most Profitable Insider Trade

Stock:
Foamix Pharma
(FOMX)
Rating:Informative Buy
Date:Mar 06, 2019 - Mar 06, 2020
Return:-21.70%
The most profitable trade made by Matthew T. Wiley

Matthew T. Wiley's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
FOMX
Foamix Pharma
Feb 24, 2020
Uninformative Buy
$335.12K
VYNE Therapeutics
Jul 02, 2021
CCO
Uninformative Sell
18.08K
$215.21K
Bioxcel Therapeutics
Jun 18, 2024
CCO
Uninformative Buy
1.03K
$4.48K
List of latest transactions for each holding click on a transaction to see Matthew T. Wiley's performance on stock

Matthew T. Wiley insider profile FAQ

What is the percentage of profitable transactions made by Matthew T. Wiley?
The percentage of profitable transactions made by Matthew T. Wiley is ―.
    What is the average return per transaction made by Matthew T. Wiley?
    The average return per transaction made by Matthew T. Wiley is ―.
      What stocks does Matthew T. Wiley hold?
      Matthew T. Wiley holds: FOMX, VYNE, BTAI stocks.
        What was Matthew T. Wiley’s latest transaction?
        Matthew T. Wiley latest transaction was an Uninformative Buy of $1.03K.
          What was Matthew T. Wiley's most profitable transaction?
          Matthew T. Wiley’s most profitable transaction was an Informative Buy of FOMX stock on March 6, 2019. The return on the trade was -21.70%.
            What is Matthew T. Wiley's role in Foamix Pharma?
            Matthew T. Wiley's role in Foamix Pharma is CCO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.